Stock Scorecard
Stock Summary for Benitec Biopharma Inc (BNTC) - $13.64 as of 4/29/2025 7:10:31 AM EST
Total Score
9 out of 30
Safety Score
26 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for BNTC
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BNTC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BNTC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BNTC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BNTC (26 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 1 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for BNTC
Financial Details for BNTC
Company Overview |
|
|---|---|
| Ticker | BNTC |
| Company Name | Benitec Biopharma Inc |
| Country | USA |
| Description | Benitec Biopharma Inc., a developing biotechnology company, is focused on the development of new genetic drugs. The company is headquartered in Hayward, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 5/12/2025 |
Stock Price History |
|
| Last Day Price | 13.64 |
| Price 4 Years Ago | 44.54 |
| Last Day Price Updated | 4/29/2025 7:10:31 AM EST |
| Last Day Volume | 15,396 |
| Average Daily Volume | 56,193 |
| 52-Week High | 16.90 |
| 52-Week Low | 5.74 |
| Last Price to 52 Week Low | 137.63% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 38.84 |
| Sector PE | 38.46 |
| 5-Year Average PE | -8.52 |
| Free Cash Flow Ratio | 4.46 |
| Industry Free Cash Flow Ratio | 18.96 |
| Sector Free Cash Flow Ratio | 41.32 |
| Current Ratio Most Recent Quarter | 25.48 |
| Total Cash Per Share | 3.06 |
| Book Value Per Share Most Recent Quarter | 3.24 |
| Price to Book Ratio | 4.57 |
| Industry Price to Book Ratio | 9.56 |
| Sector Price to Book Ratio | 22.33 |
| Price to Sales Ratio Twelve Trailing Months | 2,770.13 |
| Industry Price to Sales Ratio Twelve Trailing Months | 88.22 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.04 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 25,546,300 |
| Market Capitalization | 348,451,532 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 1 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -11.19% |
| Reported EPS 12 Trailing Months | -0.62 |
| Reported EPS Past Year | -0.81 |
| Reported EPS Prior Year | -8.36 |
| Net Income Twelve Trailing Months | -21,415,000 |
| Net Income Past Year | -21,751,000 |
| Net Income Prior Year | -19,562,000 |
| Quarterly Revenue Growth YOY | 12.50% |
| 5-Year Revenue Growth | -54.69% |
| Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 78,283,000 |
| Total Cash Past Year | 50,866,000 |
| Total Cash Prior Year | 2,477,000 |
| Net Cash Position Most Recent Quarter | 78,283,000 |
| Net Cash Position Past Year | 50,866,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 47,248,000 |
| Total Stockholder Equity Prior Year | 202,000 |
| Total Stockholder Equity Most Recent Quarter | 75,941,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -22,011,690 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.86 |
| Free Cash Flow Past Year | -19,582,000 |
| Free Cash Flow Prior Year | -18,013,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.17 |
| MACD Signal | 0.07 |
| 20-Day Bollinger Lower Band | 9.45 |
| 20-Day Bollinger Middle Band | 12.41 |
| 20-Day Bollinger Upper Band | 15.38 |
| Beta | 0.76 |
| RSI | 52.54 |
| 50-Day SMA | 10.52 |
| 150-Day SMA | 7.11 |
| 200-Day SMA | 17.29 |
System |
|
| Modified | 4/28/2025 7:19:14 PM EST |